Deferred Tax Assets, Valuation Allowance of Avidity Biosciences, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Avidity Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Avidity Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $490,371,000, a 81% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Avidity Biosciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $490,371,000 +$218,735,000 +81% 31 Dec 2025 10-K 23 Feb 2026 2025 FY
Q4 2024 $271,636,000 +$98,814,000 +57% 31 Dec 2024 10-K 23 Feb 2026 2025 FY
Q4 2023 $172,822,000 +$61,333,000 +55% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $111,489,000 +$54,796,000 +97% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 $56,693,000 +$35,377,000 +166% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $21,316,000 +$13,489,000 +172% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2019 $7,827,000 31 Dec 2019 10-K 15 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.